Novartis AG Shortterm Employee Benefits Accruals
Novartis AG (NVSEF) had Shortterm Employee Benefits Accruals of $2.25 billion as of 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes
ifrs-full:ShorttermEmployeeBenefitsAccruals · last filed 2026-02-04
- 2025-12-31: Shortterm Employee Benefits Accruals $2.25B.
- 2024-12-31: Shortterm Employee Benefits Accruals $2.18B.
- 2023-12-31: Shortterm Employee Benefits Accruals $2.33B.
- 2022-12-31: Shortterm Employee Benefits Accruals $2.32B.
| Period end | Shortterm Employee Benefits Accruals |
|---|---|
| 2025-12-31 | $2.25B 20-F · filed 2026-02-04 |
| 2024-12-31 | $2.18B 20-F · filed 2026-02-04 |
| 2023-12-31 | $2.33B 20-F · filed 2025-01-31 |
| 2022-12-31 | $2.32B 20-F · filed 2024-01-31 |
| 2021-12-31 | $2.26B 20-F/A · filed 2023-05-15 |
| 2020-12-31 | $2.29B 20-F · filed 2022-02-02 |
| 2019-12-31 | $2.46B 20-F · filed 2021-01-26 |
| 2018-12-31 | $2.53B 20-F · filed 2020-01-29 |
| 2017-12-31 | $2.33B 20-F · filed 2019-01-30 |
| 2016-12-31 | $1.99B 6-K · filed 2018-01-24 |